Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

COVID-19: the gendered impacts of the outbreak

Open access

Abstract

846 www.thelancet.com Vol 395 March 14, 2020 Policies and public health efforts have not addressed the gendered impacts of disease outbreaks. The response to coronavirus disease 2019 (COVID-19) appears no different. We are not aware of any gender analysis of the outbreak by global health institutions or governments in affected countries or in preparedness phases. Recognising the extent to which disease outbreaks affect women and men differently is a fundamental step to understanding the primary and secondary effects of a health emergency on different individuals and communities, and for creating effective, equitable policies and interventions. Although sex-disaggregated data for COVID-19 show equal numbers of cases between men and women so far, there seem to be sex differences in mortality and vulnerability to the disease. Emerging evidence suggests that more men than women are dying, potentially due to sex-based immunological or gendered differences, such as patterns and prevalence of smoking. However, current sex-disaggregated data are incomplete, cautioning against early assumptions. Simultaneously, data from the State Council Information Office in China suggest that more than 90% of health-care workers in Hubei province are women, emphasising the gendered nature of the health workforce and the risk that predominantly female health workers incur. The closure of schools to control COVID-19 transmission in China, Hong Kong, Italy, South Korea, and beyond might have a differential effect on women, who provide most of the informal care within families, with the consequence of limiting their work and economic opportunities. Travel restrictions cause COVID-19: the gendered impacts of the outbreak the intervention, a careful interpretation of the negative findings is needed. Drug development and clinical evaluation of more potent and specific latency reversal agents alone and in combination in people living with HIV receiving ART and finding new approaches to put the kill into the kick and kill regimen are still warranted to determine if this strategy might allow people living with HIV to safely stop ART and achieve a cure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(20)30526-2

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 2

  1. Carvalho, 2020, Coronavirus: Hong Kong families await return of thousands of stranded domestic helpers as the Philippines lifts travel ban, South China Morning Post
  2. 2020, Indian-American Seema Verma appointed as key member of US COVID-19 Task Force, The Economic Times

Cited by

See all 1,701

Metadata

Authors
Wenham, C., Smith, J., & Morgan, R.
Affiliations
  • London School of Economics and Political Science (GB)
  • Simon Fraser University (CA)
  • Johns Hopkins University (US)
Corresponding author
Wenham, Clare
Venue
The Lancet
Publisher
Elsevier BV
Published
2020-03
Volume
395
Issue
10227
Pages
846-848
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3010336234
Cited by
1,701
References
11
Citations by year
2026: 37 · 2025: 45 · 2024: 110 · 2023: 205 · 2022: 324 · 2021: 519 · 2020: 460
FWCI
504.31
Type
journal article
Language
en
Open access
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (acceptedVersion)
Funders
  • Gilead Sciences
  • Australian Centre for HIV and Hepatitis Virology Research
  • Wellcome Trust
  • ViiV Healthcare
  • Leidos
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Social Sciences › Sociology and Political Science › Gender, Health, and Social Inequality
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
sex-disaggregated data, gender analysis, healthcare workers, gender equity in health, gender and health policy, smoking, health equity, gender mainstreaming, women's economic security
MeSH terms
COVID-19, Disaster Planning, Disease Outbreaks, Female, Gender Identity, Health Personnel, Health Policy, Humans, Male, Pneumonia, Viral, Policy Making, Women's Health, Caregivers, Coronavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COVID-19: the gendered impacts of the outbreak. https://app.cochat.ai/papers/10.1016/s0140-6736(20)30526-2
The paper
Wenham, C., Smith, J., & Morgan, R. (2020). COVID-19: the gendered impacts of the outbreak. The Lancet. https://doi.org/10.1016/s0140-6736(20)30526-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.